Pretreatment With G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis

Stem Cells International - Egypt
doi 10.1155/2019/1726743
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

HDAC Inhibitors as Antifibrotic Drugs in Cardiac and Pulmonary Fibrosis

Therapeutic Advances in Chronic Disease
Medicine
2019English

FRI0461 Efficacy and Safety of Antifibrotic Agents in Idiopathic Pulmonary Fibrosis

2018English

Idiopathic Pulmonary Fibrosis (IPF) ― Common Practice in Poland Before the “Antifibrotic Drugs Era”

Advances in Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Angiogenic Potential of BM MSCs Derived From Patients With Critical Leg Ischemia

Bone Marrow Transplantation
TransplantationHematology
2011English

Impact of Novel Antifibrotic Therapy on Patient Outcomes in Idiopathic Pulmonary Fibrosis: Patient Selection and Perspectives

Patient Related Outcome Measures
2018English

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis

Stem Cells International
Cell BiologyMolecular Biology
2020English

Degradation of BM SDF-1 by MMP-9: The Role in G-CSF-Induced Hematopoietic Stem/Progenitor Cell Mobilization

Bone Marrow Transplantation
TransplantationHematology
2008English

Pulmonary Administration of a Dry Powder Formulation of the Antifibrotic Drug Tilorone Reduces Silica-Induced Lung Fibrosis in Mice

International Journal of Pharmaceutics
Pharmaceutical Science
2018English

The Effect of G-CSF in a Myocardial Ischemia Reperfusion Model Rat

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy